DSIP vs Melanotan II
A comprehensive, data-driven comparison of DSIP (Delta Sleep-Inducing Peptide) and Melanotan II (MT-2). Compare efficacy, side effects, costs, FDA approval status, and clinical evidence to make an informed decision.
Side-by-Side Comparison
| Property | DSIP Delta Sleep-Inducing Peptide | Melanotan II MT-2, Melanotan 2 |
|---|---|---|
| FDA Status | Category 2 | Not submitted |
| Category | Sleep | Sexual Health |
| Primary Use | Sleep disorders and stress reduction | Tanning and sexual dysfunction (research) |
| Weight Loss % | N/A | N/A |
| Monthly Cost | $35 - $70/mo | $30 - $60/mo |
| Administration | Subcutaneous injection | Subcutaneous injection |
| Typical Dose | 100-300mcg before bed | 0.25-1mg 2-3x per week |
| Frequency | Daily | As needed |
| Mechanism | Neuropeptide that may modulate sleep patterns, reduce stress, and regulate circadian rhythms | Melanocortin receptor agonist that stimulates melanogenesis for tanning and has effects on sexual arousal |
| Common Side Effects |
|
|
| Serious Side Effects |
|
|
| Evidence Quality | Emerging | Low |
| Clinical Trial Phase | N/A | N/A |
Key Differences
- 1Melanotan II is generally more affordable ($30 - $60/mo) compared to DSIP ($35 - $70/mo).
- 2DSIP is dosed daily, while Melanotan II is as needed.
- 3Melanotan II has low-quality evidence, while DSIP has emerging-quality evidence.
- 4They belong to different categories: DSIP (Sleep) vs Melanotan II (Sexual Health).
Which Is Better For...
Melanotan II
More budget-friendly option with lower monthly costs
Melanotan II
More convenient dosing schedule (as needed)
DSIP
Fewer commonly reported side effects
Melanotan II
Stronger clinical evidence base to support its use
Cost Comparison
| Peptide | Monthly Cost Range | FDA Status | Manufacturer |
|---|---|---|---|
| DSIP | $35 - $70/mo | Category 2 | Various research labs |
| Melanotan II | $30 - $60/mo | Not submitted | Various research labs |
Prices are estimated monthly costs and may vary based on pharmacy, insurance coverage, and manufacturer assistance programs. Costs for non-FDA-approved peptides reflect research compound pricing.
Frequently Asked Questions
DSIP works via Neuropeptide that may modulate sleep patterns, reduce stress, and regulate circadian rhythms. Melanotan II works via Melanocortin receptor agonist that stimulates melanogenesis for tanning and has effects on. They differ in FDA approval status, efficacy data, and cost.
DSIP typically costs $35 - $70/mo, while Melanotan II costs $30 - $60/mo. Prices may vary by pharmacy, insurance coverage, and manufacturer programs.
DSIP is not FDA-approved (Category 2). Melanotan II is not FDA-approved (Not submitted). FDA approval indicates the treatment has met rigorous safety and efficacy standards.
Common side effects of DSIP include Injection site reactions, Drowsiness, Vivid dreams. Common side effects of Melanotan II include Nausea, Flushing, Spontaneous erections. Always consult a healthcare provider about potential side effects.
Switching between peptide therapies should only be done under the guidance of a qualified healthcare provider. They can evaluate your medical history, current response, and determine the safest transition protocol.
Learn More
DSIP (Delta Sleep-Inducing Peptide) is a neuropeptide first discovered in 1977 in the brains of sleeping rabbits. Research suggests it may have broader effects on stress response, pain modulation, and...
View Full DSIP GuideMelanotan II is a synthetic analog of alpha-melanocyte stimulating hormone that binds to melanocortin receptors. Originally developed for skin tanning protection against UV damage, it was found to hav...
View Full Melanotan II GuideOther Popular Comparisons
Medical Disclaimer
The information provided on this page is for educational and informational purposes only and does not constitute medical advice. This comparison between DSIP and Melanotan II should not be used as a substitute for professional medical guidance. Always consult a qualified healthcare provider before starting, stopping, or modifying any peptide therapy. Clinical data cited may be from ongoing trials and is subject to change. Individual results may vary significantly. PeptideVS does not endorse, recommend, or promote the use of any specific peptide for medical treatment.